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Introduction
The District of Columbia has the highest overall age-adjusted 
cancer mortality rate in the United States.1 Of special concern is our 
mortality ranking as 1st in female colorectal (18.8 per 100,000), prostate 
(37.6 per 100,000), breast (29.4 per 100,000), and cervical (3.7 per 
100,000).2 Early detection and behavioral risk reduction activities can 
greatly reduce late stage diagnosis and cancer mortality. Remarkably, 
many cancers have strong familial and genetic components that can be 
identified to determine individuals at risk before diagnosis.3 Therefore, 
the collection of Family Health History (FHH) information may assist 
in early cancer detection; cancer risk reduction; improved utilization 
of cancer screening; chemoprevention; and surgical intervention for 
inherited cancers. We propose that incorporation and utilization of 
FHH in medical practice may also have an impact on the District’s 
cancer mortality rate. FHH is a practical, cost-effective, and engaging 
tool that can be used to teach people how genetics, environment, and 
behaviors interact to affect health. It is well established that family 
health history is also a risk factor for many health problems including 
heart disease, asthma, cancer, diabetes, stroke, and even pregnancy 
related problems.4 By knowing one’s FHH, individuals and families 
can make targeted lifestyle and screening choices to lower their risk of 
developing diseases that run in the family. In 2004, the U.S. Surgeon 
General, Dr. Richard H. Carmona, launched a Family History Initiative 
where all Americans were encouraged to sit down with their families 
during the holiday season and collect their FHH. Thanksgiving Day 
was declared National Family History Day and has continued to be an 
annual event sponsored by the U.S. Surgeon General.5 A recent survey 
affirmed the public’s growing interest in FHH. Results showed that 
96% of Americans felt knowing their FHH was important but only 
30% collected information from their relatives to develop a FHH. 
The lack of awareness of FHH by patients and their providers has 
far reaching health consequences, and diminishes opportunities for 
optimal health interventions.
Purpose of the present study
To address the burden of familial and genetically linked breast, 
colorectal, ovarian and prostate cancers in Washington, DC, first, 
the Howard University Cancer Center (HUCC), the National Human 
Genome Center (NHGC) at Howard University and the District of 
Columbia Department of Health developed and implemented an 
evidence-based community-level risk assessment tool aimed at 
collecting family medical history, for breast, colorectal, ovarian 
and prostate cancers. The Know Your Family Ancestry, Conditions, 
Traits, and Traditions (Know Your FACTs©, KYF) Initiative, is an 
outreach and educational program aimed at increasing awareness of 
the importance of obtaining family medical histories and the value 
of genetic testing and counseling. All materials and information 
were tailored to meet the cultural and linguistic needs of the African 
American and Latino community of Washington, DC. This project 
was a natural extension of the Community Genetics Education 
Network (CGEN) Project that aimed to increase awareness of genetic 
information and access to appropriate genetics education programs 
and services in underserved and underrepresented populations. The 
purpose of this study was to determine individuals’ intentions to use 
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Abstract
Family Health History (FHH) is a practical, cost-effective, and engaging tool that is 
important in identifying individuals at an increased risk for disease. The “Know Your 
FACTs©” (KYF) program has educated underserved communities about cancer risks, 
urged individuals to share their FHH with healthcare providers and family members, 
and encouraged cancer screening and risk reduction activities. In addition to containing 
instructions for the collection of FHH, the KYF tool included surveys which were 
distributed in underserved community-based settings to determine individuals’ intentions 
to use and share their FHH. Our results demonstrate that 88.9% intend to use or utilized the 
FHH tool, 91.1% aim to share or shared the tool with their family members, 86.7% intend 
to share or shared their FHH with their doctor, and 53.3% would make lifestyle changes. 
Since the implementation of KYF, patient referrals to genetic counseling have increased 
considerably from 1 to 11 referrals monthly. These findings support the importance of 
the “Know Your FACTs©” program by demonstrating that the community is interested 
in health and important services such as genetic counseling. As a result of this compelling 
effort, genetic counseling services are now being offered at the Howard University Cancer 
Center for the first time.
Keywords: genetics, community education, genomic education, family health history 
(FHH), underserved, african american, hispanic, public health, genetic counseling, 
screening tool
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and share their FHH once exposed to the Know Your FACTs© FHH 
tool and to evaluate its impact on referrals for genetic counseling 
services. This study provides a descriptive analysis of the development 




Participants were African American and Hispanic individuals 
from various communities within the Washington, DC metro area 
between June and September 2012. Brochures were distributed to 
participants in locations that treat underserved communities such as 
Howard University Hospital and Howard University Hospital health 
fair and expositions, in addition to community partners working with 
underserved communities such as Nueva Vida (a support network 
for Latinas with cancer) and East of the River Clergy, Police, and 
Community Partnership. This study explored individuals’ intentions 
to use and share their FHH once exposed to the KYF tool (Table 1 & 
Table 2).
Table 1 Locations and dates of brochures’ distribution and dissemination
Distribution location Number of brochures distributed Date(s)
Oncology Clinics 90 June - Sept. 2012
Health Fair (Community Health Expo) 50 14-Jul-12
Dr. Oz Health Fair at Howard University 100 Sept. 5, 2012
Howard University College of Medicine Department of Community and Family Medicine 50 Sept. 13, 2012
Howard University College of Medicine Department of Oncology 50 Sept. 13, 2012
Howard University College of Medicine Department of Pediatrics 50 Sept. 13, 2012
CGEN list serve 250 Sept. 14, 2012
East of the River Clergy, Police, and Community Partnership 50 Sept. 14, 2012
Howard University Cancer Center “Mammoday” Program 40 Sept. 15, 2012
Nueva Vida (community partner) 75 Sept. 15, 2012
Total 805








Education Total Number (45)%
Some High school 7 15.56%
High school diploma 14 31.11%
Some College 11 24.44%
College Degree 10 22.22%
Graduate or Professional School 3 6.67%
Race/Ethnicity Total Number (44)%







The survey instrument consisted of items assessing demographic 
characteristics, including age, gender, zip code, education and self-
reported racial/ethnic background. Participants were asked if they 
would utilize the tool themselves and if they would share it with 
family members or healthcare professionals. Additionally, participants 
provided information about changing lifestyle habits, such as smoking 
and exercise, as well as physicians’ recommendations based on the 
information learned from the utilization of the KYF tool. Because 
several FHH instruments were available at the time of this study, KYF 
brochures were adapted from preexisting materials such as the Genetic 
Alliance’s booklet on FHH “Does It Run In the Family?”. The KYF 
materials included information about: 1) FHH, 2) genetic resources 
and services, and 3) cancer risk information. Specifically, the FHH 
information consisted of details on how and what information to collect 
from family members and a tool that could be used to facilitate the 
collection of one’s FHH. Information about local resources for genetic 
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counseling, education and testing available at the NHGC as well as 
the benefits of utilizing genetic testing and counseling for moderate to 
high risk African American and Latino/Latina residents were included. 
The document also provided risk information that included, but was 
not limited to, having 1) family members with cancer under the age 
of 50 and 2) many family members on the same side of the family 
with cancer. The tools were culturally and linguistically relevant for 
African Americans and Latino/Latina residents of Washington, DC 
and were also available free of charge.
Procedures
More than eight hundred and five brochures were distributed 
by the research team to African American and Hispanic residents, 
respectively, in community-based settings, at Howard University 
Clinics, cancer-screening clinics throughout the Washington, DC 
area, community health fairs, and directly to community partners 
(Table 1). Additionally, materials were mailed to HUCC community 
partners and individuals enrolled in the Howard University Consumer 
Genetics Education Network (CGEN) list serv. Completed surveys 
were collected and analyzed by the KYF team.
Data analysis
All brochures contained perforated surveys that could be mailed to 
the HUCC or handed in to community stakeholders. Postage was paid 
to increase survey participation. After receipt of surveys, descriptive 
statistics were performed.
Results
The KYF Team received forty-five surveys. The demographics of 
the individuals who completed the survey are listed in Table 2. Briefly, 
93.3% of the surveys were completed by women, most of who were 
over the age of 36 (88.89%). Education varied among the participants; 
15.6% had some high school education while 31.1% received a high 
school diploma. More than 46.7% had some college or completed 
a college degree, whereas, 6.7% were graduated from professional 
schools. Regarding race and ethnicity, 59.1% of the respondents 
were African American while 18.8% were Latino or Hispanic. Of the 
respondents, 88.89% of the participants noted that they used or intend 
to use the FHH collection tool; 91.1% also checked that they intend to 
share the tool with their family members. Similarly, 77.78% checked 
that they would seek cancer screening after use of the tool. We did not 
inquire about reasons they would not seek cancer screening. Regarding 
their primary care doctors, 86.67% also revealed that they have or 
will share their FHH tool with their doctor. Most of the individuals 
indicated that they shared the tool with their physicians, and 42.22% 
of physicians made recommendations based on the patient’s family 
history. After using the FHH tool, many participants noted that they 
would make behavioral changes. Specifically, 58.33% intend to do 
breast self-exams; 50% intend to change their diet; 70.83% intend to 
exercise; and 16.67% intend to quit smoking (Table 3) (Appendix).
Table 3 Survey results
Yes % Yes %
N=(44) n (Total Respondents)
Will you use this FHH tool? 40 88.89% 40 (44) 90.91%
Will you share this FHH tool with your family? 41 91.11% 41 (44) 93.18%
Will you seek cancer screening after using this tool? 35 77.78% 35 (42) 83.33%
Will you share this FHH tool with your doctor? 39 86.67% 39 (43) 90.70%
Did your doctor make any recommendations based on the information 
from this FHH tool? 19 42.22% 19 (33) 57.58%
Did your doctor suggest you make any of the following lifestyle changes 
after using this tool?
24 53.33% 14 (24) 58.33%
Suggestions
Breast Self-Exam 14 (24) 58.33%
Diet Changes 12 (24) 50.00%
Exercise 17 (24) 70.83%
Quit Smoking 4 (24) 16.67%
Table 4 Referral sources of participants referred to genetic counseling clinic
Referral sources n=45  Percentage%
Physician 38 84.44%
Self-Referral 5 11.11%
Referred by Patients’ Navigator 2 4.44%
Discussion
A positive family history is a risk factor for many chronic 
diseases. Additionally, a positive family health history may also be 
an indication of a genetic predisposition, shared environments, and 
shared behaviors. By identifying women with a strong family history 
of breast cancer and providing genetic counseling and testing, we can 
provide patients with the tools necessary to reduce their risk of breast 
cancer – or prevent disease all together - in various ways. In some 
families, the development of some cancers, such as breast and ovarian, 
may be caused by a BRCA1 or BRCA2 mutation and considered 
part of hereditary syndromes such as Hereditary Breast and Ovarian 
Cancer (HBOC) syndrome.6 In fact, the US Preventive Services Task 
Force (USPSTF)recommends that women with a family history of 
breast cancer are at increased risk for BRCA1 or BRCA2 mutations 
and should be referred for genetic testing and counseling (GTC).7 
Conceivably, these women will benefit from genetic counseling 
- a resource that allows informed decision-making about testing 
and options to reduce their cancer risk. For example, women with 
BRCA1/2 genetic mutations have choices that include prophylactic 
surgery to prevent breast and ovarian cancer, chemoprevention, to 
surveillance or watchful waiting. There are limited data that support 
minority uptake of genetic counseling and testing.8-13 The majority 
of findings consistently reveal that US Whites access cancer genetic 
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counseling and testing more frequently than AAs.14 For example, 
Armstrong et al., found that women in a case-control study, seen in a 
university based primary care setting, African American women with 
a FHH similar to white women were less likely to undergo BRCA1 
and BRCA2 genetic testing.15 Therefore, the use of GTC for primary 
cancer prevention is yet another area of medicine in which disparities 
occur. Family health history is an underutilized resource that has the 
potential to optimize individuals and familial health outcomes. A 
previous study found that when family medical histories are carefully 
and systematically obtained and collected, there is “moderately good 
agreement” between family histories obtained by family members 
and data obtained in the cancer registry.16 Therefore the collection of 
family medical history, particularly as it relates to breast, prostate, 
colorectal, and ovarian cancers, represents a valuable public health 
tool to assist individuals and their health care providers to accurately 
assess risk and develop care plans accordingly.
Study limitations
This study has limitations that may have restricted the effects 
our results. Over 800 brochures were distributed, however; only 45 
surveys were received indicating a 5% return rate. This percentage 
does not reflect the utilization and effects of the KYF tool for the 
majority of individuals encountered. Participants might have found 
the information within the brochure valuable, but did not return 
their surveys for data collection. Additionally, the small sample 
size prevented us from performing some bivariate and multivariate 
analyses. Another limitation of the study is that our survey was 
assessed by self-report. Participants may have over- and/or under-
reported their behaviors regarding the impact of the KYF tool on their 
personal lifestyle, family health, and encounters with their healthcare 
providers. Also, several questions were written in past tense, and 
based on the assumption that the participant had time to utilize the 
FHH tool, speak with family members, and schedule an appointment 
with their healthcare physician to discuss the tool (if they chose to do 
so), prior to returning their survey to the researchers. The tool also 
provides a challenge for accurately identifying the participants who 
would benefit from a healthcare provider’s recommendation to change 
lifestyle behaviors, such as smoking cessation or more frequent 
screenings. A few of the questions assume that the participant may 
have a significant personal and/or FHH, or lifestyle behaviors that 
would prompt the physician to suggest making a change. Although 
the number of surveys received did not represent the majority of the 
participants encountered, the FHH brochures increased awareness 
about FHH and encouraged community stakeholders to share their 
family health histories. This success is evident by the increase in 
referrals to genetic counseling.
Research recommendations
In the future, we plan to revise our survey tool to allow for 
more comprehensive reports from participants. We may also 
consider separating our survey into two parts, where the first will 
assess participant views and perceptions of the KYF brochure and 
information provided, while the second will assess the outcome 
of the tool regarding their utilization. Limited studies have been 
published evaluating the health care outcomes and decisions made 
between health care providers and patients equipped with their FHH 
information. Additional work will include a longitudinal analysis of 
outcomes associates with sharing FHH information with relatives. 
As a means of increasing physicians’ abilities to incorporate FHH 
information into their practices, it would be helpful if providers could 
contribute and offer suggestions on the development of FHH tools that 
could be seamlessly integrated into their health care practices. These 
practices should be applied in an array of health care settings such 
as urban health care center, community health care center, outpatient 
clinics etc., in order to capture variations in use of FHH information 
in patient care. Future survey instruments should test the validation of 
the instrument and explore the impact of this instrument when made 
available online.
Implications for genetic counseling practice
As a result of our efforts, the genetic counseling clinic at the 
HUCC, has received many inquiries regarding genetic counseling and 
testing from community members and physicians. In total, 100 family 
health histories were collected by community members and evaluated 
by genetic counselors (n=90 at the HUH Oncology clinic and n=10 
at the Community Health Expo). Notably, 38 (84.44%) individuals 
were referred by their physicians, 5 (11.11%) were self-referred, and 
2 (4.44%) were referred by community patient navigators (Table 4). 
Genetic counseling and testing has been an under-utilized resource 
within underserved communities, therefore having a program such 
as KYF available to provide this opportunity has been paramount to 
understanding the need for this service within the community.8,11,17 
Additionally, having African-American and Latina genetic 
counselors, research assistants, and principal investigators as the 
leaders of this program has build trust within the community, in turn 
leading to successful outcomes and the opportunity to break barriers 
regarding minority and underserved recruitment and participation in 
research. African American genetic counselors may inherently have 
the skills to fill the gaps in effective communication that plague the 
health care system and contribute to health disparities, because of 
their understanding of the diverse cultures, backgrounds and issues 
that impact the community. Through KYF, underserved communities 
in the Washington DC metro area have learned of the availability of 
genetic testing, and as a result, the scientific community will learn 
of the genetic and genomic variations that are potentially playing 
a role in health outcomes within these communities. In fact, this 
activity resulted in the development of the cancer genetics counseling 
program at Howard University which recently found that African-
American and Hispanic women with breast cancer or with family 
histories of the disease likely will see a genetic counselor when 
given the opportunity to meet with one (manuscript in preparation). 
Also, the Howard University Cancer Center experienced a 40-fold 
increase in patients seeking genetic guidance with more than 200 
patient encounters occurring within 21 months to two years after the 
implementation of the KYF program (manuscript in preparation). It 
is also well known that a barrier to utilization of genetic counseling 
and testing lies with the referring physician. The role of the physician 
in identifying and referring high-risk patients for genetic counseling 
cannot be underestimated. Advances in the field have necessitated 
that healthcare providers integrate genetics into the risk assessment 
and management of families with cancer. However, most primary 
care physicians (PCPs) have little experience or training relevant to 
genetic testing, and many lack knowledge and skill in this area of 
practice.18,19 Additionally, research has shown that minority-serving 
physicians were less likely to have ordered a genetic test to assess 
breast cancer risk and were also less likely to have referred a patient 
for genetic testing to a genetics center or counselor compared to those 
serving fewer minority patients.20 Moreover, Shields and colleagues 
found that physicians serving a disproportionate share of Medicaid 
patients were significantly less likely to have referred a patient to 
a genetic counselor, but those physicians who received training in 
clinical genetics though continuing medical education (CME) courses 
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were significantly more likely to refer patients for genetic testing and 
counseling (GTC). In short, this is also critical issue that warrants 
intervention, especially in the age of precision medicine.
A study of 2,250 internists, gynecologists, and oncologists from 
the Eastern United States reported that knowledge of breast cancer 
genetics was relatively low overall, with only 25% of physicians 
answering all knowledge base questions in genetics correctly.21 
Among oncologists, knowledge was associated with having a 
patient previously tested for BRCA mutations. Among primary care 
physicians, the numbers were even lower (40%). Not surprisingly, 
physicians who felt confident and qualified to recommend counseling 
were much more likely to do so. Another important factor in predicting 
genetic services is patient inquiry as to whether they can or should be 
tested.22 Even if a physician fails to recommend genetic counseling, 
informed individuals may act as their own health care advocates. This 
data supports training and education for both PCP and patients, which 
we will address in the next phase of the KYF program.
Conclusion
Obtaining an accurate family medical history is particularly 
important in identifying individuals who may be predisposed to 
various cancers. Family health history has also been a valuable tool 
in preventive medicine. Family history taking, as part of a disease-
specific approach, aims to identify the risk of selected single gene 
disorders for the purpose of offering appropriate specialist referral 
and management. However, family histories must be adequate to 
enable PCPs to make appropriate clinical and prevention decisions. 
Ultimately, we believe that the success of this project was due to 
facilitating accurate FHH collection at the community level. We show 
that the community is interested in their health and that our efforts 
to increase awareness of FHH also increased the use of genetic 
counseling services at Howard University. More specifically, AA have 
reported that cancer genetic risk assessment would help: a) motivate 
them to perform breast self-examinations and/or mammograms 
more regularly; b) inform family members about their potential risk 
of developing cancer; and c) improve decision-making regarding 
preventive care. These findings supported the development and 
implementation of our “Know Your FACTs” program and educational 
materials in communities of color like Washington, DC where the 
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